ElevateBio: Develops and manufactures cell and gene therapies.
12+ YOE5+ MgmtPhD required; 12+ years in gene editing/genome engineering with 5+ years senior leadership and 5+ years client-facing services experience. Deep expertise in CRISPR/NGS, delivery platforms, GMP, and translational development.
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
2+ YOEExperience in gene editing, immunology, cloning, ddPCR, flow cytometry, primary T cell culture, and quantitative biology; PhD or equivalent experience; strong teamwork and communication skills.
OcugenNASDAQ: OCGN: Develops gene and cell therapies for rare blindness diseases.
8+ YOEBachelor’s or Master’s in life sciences; 8+ years regulatory affairs in biotech/pharma with gene therapy; FDA interactions; INDs/CTAs/BLAs; cross-functional collaboration.
DoverNYSE: DOV: Manufactures diversified industrial equipment and engineered components globally.
5+ YOEBachelor's degree; 3+ years technology/product development; 5+ years biopharma experience; experience in cell therapy/gene therapy and single-use fluid-handling; engineering/automation experience; strong strategic, communication, and problem-solving skills; up to 25% travel.
University of California: Public research university system providing academic, medical, and research services.
3+ YOEBachelor's in biological sciences or equivalent, valid CA driver's license, 3+ years FDA/IND stem cell clinical experience, clinical research and lab experience, HIPAA/IRB/JCAHO knowledge, adverse event reporting, project management.
Director, Cell & Gene Therapy Research Technology (Boston)
Boston, Massachusetts, United States
$198k-$297k/yrHybridFull Time
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
10+ YOEBachelor's in technology or equivalent, 10+ years relevant experience, 3+ years in cell & gene therapy, people leadership, GxP/SOX compliance, budget and vendor management, product-owner/demand-shaping experience.
Beam TherapeuticsNASDAQ: BEAM: Develops precision genetic medicines using base editing technology.
8+ YOEBachelor's degree required; 8+ years healthcare experience with direct apheresis experience; experience in treatment center onboarding, cell therapy operations, and regulatory compliance (FACT,AABB,GxP).
Rocket PharmaceuticalsNASDAQ: RCKT: Developing gene therapies for rare and life-threatening diseases.
12+ YOENursing degree required with MSN and 10+ years or BSN and 12+ years in clinical research drug development; knowledge of clinical development, ICH/GCP, and adverse event management; strong collaboration and communication skills.
Mass General Brigham: Provides integrated medical care, research, and clinical training services.
5+ YOE1+ MgmtPreclinical project management experience in gene editing or gene therapy; cross-functional team leadership; regulatory compliance knowledge; strong communication and budgeting skills.
Merge Labs: Developing high-bandwidth non-invasive brain-computer interfaces using biotechnology.
Ph.D. or equivalent research experience in bioengineering or related field; hands-on focused ultrasound gene delivery experience; expertise in gene delivery modalities, in vivo experiment design and evaluation; strong communication and collaboration skills.
IQVIANYSE: IQV: Provides clinical research and data analytics for pharmaceutical companies.
5+ YOEPhysician (MD/DO or MD/PhD) with 5+ years of clinical research in cell and gene therapy, gene therapy/gene editing; licensed physician; strong regulatory and clinical development knowledge.
SartoriusXETRA: SRT3: Providing equipment and technologies for biopharmaceutical research and manufacturing.
3+ YOEBachelor’s in Life Sciences or Engineering; 3+ years gene therapy experience; 1+ year customer-facing or sales experience; Salesforce proficiency.
United TherapeuticsNasdaq: UTHR: Develops rare disease therapies and manufactured transplantable organs.
5+ YOEMaster’s degree with 8+ years or PhD with 5+ years in immunology or related field; strong immunology, transplant biology, and gene therapy expertise; experience with viral and non-viral gene delivery; assay development; mentoring and cross-functional collaboration.
Rocket PharmaceuticalsNASDAQ: RCKT: Advances gene therapies for rare and life-threatening diseases.
10+ YOENursing degree with 10+ years clinical research drug development experience; MSN preferred; experience with cell or gene therapy; strong regulatory and GCP knowledge; excellent communication and cross-functional collaboration.
The Jackson Laboratory: Conducts genomic research and produces specialized laboratory mouse models.
10+ YOE3+ MgmtPh.D. in life sciences with 10+ years in preclinical drug development and at least 3 years in leadership; experience in gene therapies and genomic medicine.
Mouse genetics, In vivo pharmacology, iPSC models, Organoids, GLP, DMPK, PK/PD, Vector engineering
Catalent: Global provider of drug development and manufacturing solutions.
10+ YOE10+ MgmtBachelor's in a scientific/technical discipline required (MS/MBA preferred). 10+ years senior management experience with P&L leadership in Pharma Services, matrix leadership, global customer engagement, GMP/ISO/regulatory knowledge, and talent development.
SIOP, LEAN, Good Manufacturing Practices (GMP), International Organization for Standardization (ISO)
St. Jude Children's Research Hospital: Pediatric research hospital treating children with catastrophic diseases.
8+ YOEDesign and execute genomics and gene‑editing research, perform wet‑lab and computational analyses, and communicate findings; bachelor's degree plus substantial relevant experience required.
St. Jude Children's Research Hospital: A pediatric treatment and research hospital for childhood diseases.
8+ YOEBachelor's degree required with 8+ years experience (6 with Master's,3 with PhD). Expertise in genomics, gene editing, and bioinformatics; ability to design experiments, analyze complex datasets, and communicate results.